Related Experiment Video
Updated: Nov 5, 2025

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
Multiple organ failure might be an indication for prophylactic antifungal therapy in acute pancreatitis
Caihong Ning1,2,3, Shuai Zhu1,2,3, Shuyi Zhou1,2,3
1Department of Pancreatic Surgery, Xiangya Hospital, Central South University, 87 Xiangya Rd, Changsha, 410008, Hunan, People's Republic of China.
Purpose:
Significant conflicts regarding prophylactic antifungal treatment in acute pancreatitis (AP) exist among current literatures and guidelines. The key to resolving this controversial issue is to identify risk factors for intra-abdominal fungal infection (AFI) among patients with AP.
Methods:
A single-center, retrospective cohort of 826 patients with AP between January 2014 to December 2019 was analysed to study the risk factors of AFI.
Results:
Of the 826 patients with AP, 10 patients (1.2%) developed AFI, including 2 cases in moderately severe AP (MSAP) and 8 in severe AP (SAP). The incidence of AFI was significantly higher in patients with SAP compared with MSAP and mild AP (10.3 vs. 0.8% vs. 0, P < 0.001). SAP patients with AFI were more likely to have multiple organ failure (MOF) (OR = 13.4; 95% CI 1.6-115.5), organ failure lasting more than 1 week (OR = 5.1; 95% CI 1.0-27.0), and surgical intervention within first week of admission (OR = 7.4; 95% CI 1.0-53.6). Multivariable analysis identified MOF (OR = 14.3; 95% CI 1.2-173.8) as the only independent risk factor of AFI.
Conclusion:
MOF might be the indication of prophylactic antifungal therapy in patients with AP.
Insights
Identifying risk factors for intra-abdominal fungal infections in acute pancreatitis is crucial. Multiple organ failure emerged as the sole independent predictor, suggesting its potential role in guiding prophylactic antifungal therapy decisions.
Area of Science:
- Gastroenterology and Hepatology
- Infectious Diseases
- Critical Care Medicine
Background:
- Prophylactic antifungal treatment in acute pancreatitis (AP) remains controversial.
- Identifying risk factors for intra-abdominal fungal infection (AFI) is key to resolving this debate.
Purpose of the Study:
- To identify independent risk factors for intra-abdominal fungal infection (AFI) in patients with acute pancreatitis (AP).
- To inform guidelines and clinical practice regarding prophylactic antifungal therapy in AP.
Main Methods:
- Retrospective cohort study of 826 AP patients from January 2014 to December 2019.
- Analysis focused on identifying risk factors associated with the development of AFI.
Main Results:
- AFI occurred in 1.2% of AP patients, with a significantly higher incidence in severe AP (SAP) (10.3%) compared to moderately severe AP (MSAP) (0.8%) and mild AP (0%).
- SAP patients with AFI were more likely to experience multiple organ failure (MOF), prolonged organ failure (>1 week), and early surgical intervention (<1 week).
- Multivariable analysis identified MOF as the only independent risk factor for AFI (OR=14.3; 95% CI 1.2-173.8).
Conclusions:
- Multiple organ failure (MOF) may serve as a critical indicator for considering prophylactic antifungal therapy in acute pancreatitis patients.
- These findings could help refine treatment strategies and reduce antifungal-related complications.
More Related Videos
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

